June 18, 2007
Treatment of Restless Legs Syndrome, Recruiting Patients for Study
To evaluate the efficacy of botulinum toxin, type A, (BoNT) for the treatment of primary Restless legs syndrome (RLS). We hypothesize that BoNT will be effective at decreasing the deep sensory discomfort of RLS.
Read More
